What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Biologics

PUBLISHER: TechNavio | PRODUCT CODE: 1645484

PUBLISHER: TechNavio | PRODUCT CODE: 1645484

Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2025-2029

PUBLISHED: January 11, 2025

PAGES: 203 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The epidermal growth factor receptor (EGFR) inhibitors market is forecasted to grow by USD 10732.5 mn during 2024-2029, accelerating at a CAGR of 10.5% during the forecast period. The report on the epidermal growth factor receptor (EGFR) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in the prevalence of major cancer indications, increasing awareness and adoption of personalized medicine, and advancements in technology and research.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	9.4%
CAGR	10.5%
Incremental Value	$10732.5 mn

Technavio's epidermal growth factor receptor (EGFR) inhibitors market is segmented as below:

By Indication

Lung cancer
Colorectal cancer
Breast cancer
Others

By Distribution Channel

Retail pharmacies
Hospital pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in research areas for treatment of various types of cancer as one of the prime reasons driving the epidermal growth factor receptor (EGFR) inhibitors market growth during the next few years. Also, rise in number of drug pipelines and increasing reimbursement programs will lead to sizable demand in the market.

The report on the epidermal growth factor receptor (EGFR) inhibitors market covers the following areas:

Epidermal Growth Factor Receptor (EGFR) Inhibitors Market sizing
Epidermal Growth Factor Receptor (EGFR) Inhibitors Market forecast
Epidermal Growth Factor Receptor (EGFR) Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epidermal growth factor receptor (EGFR) inhibitors market vendors that include Amgen Inc., ASSERTIO HOLDINGS INC., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Checkpoint Therapeutics Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Hansoh Pharmaceutical Group Co. Ltd., Hutchison China Meditech Ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Johnson and Johnson Inc., Lutris Pharma, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Puma Biotechnology Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the epidermal growth factor receptor (EGFR) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR72701

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2019 - 2023
- Historic Market Size - Data Table on Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2019 - 2023 ($ million)
5.2 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on global epidermal growth factor receptor (EGFR) inhibitors market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Indication

8.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)
8.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
8.3 Lung cancer - Market size and forecast 2024-2029
- Chart on Lung cancer - Market size and forecast 2024-2029 ($ million)
- Data Table on Lung cancer - Market size and forecast 2024-2029 ($ million)
- Chart on Lung cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Lung cancer - Year-over-year growth 2024-2029 (%)
8.4 Colorectal cancer - Market size and forecast 2024-2029
- Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ million)
- Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ million)
- Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%)
8.5 Breast cancer - Market size and forecast 2024-2029
- Chart on Breast cancer - Market size and forecast 2024-2029 ($ million)
- Data Table on Breast cancer - Market size and forecast 2024-2029 ($ million)
- Chart on Breast cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Breast cancer - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.13 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.14 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
11.15 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
14.5 ASSERTIO HOLDINGS INC.
- ASSERTIO HOLDINGS INC. - Overview
- ASSERTIO HOLDINGS INC. - Product / Service
- ASSERTIO HOLDINGS INC. - Key offerings
- SWOT
14.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
14.7 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
14.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
14.9 Checkpoint Therapeutics Inc.
- Checkpoint Therapeutics Inc. - Overview
- Checkpoint Therapeutics Inc. - Product / Service
- Checkpoint Therapeutics Inc. - Key offerings
- SWOT
14.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
14.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.12 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
- Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
- Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
- SWOT
14.13 Johnson and Johnson Inc.
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key news
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Segment focus
- SWOT
14.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
14.15 Otsuka Holdings Co. Ltd.
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key news
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Segment focus
- SWOT
14.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
14.17 Puma Biotechnology Inc.
- Puma Biotechnology Inc. - Overview
- Puma Biotechnology Inc. - Product / Service
- Puma Biotechnology Inc. - Key offerings
- SWOT
14.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR72701

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Indication - Market share 2024-2029 (%)
Exhibits37: Data Table on Indication - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Indication
Exhibits39: Data Table on Comparison by Indication
Exhibits40: Chart on Lung cancer - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Lung cancer - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Lung cancer - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Lung cancer - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%)
Exhibits48: Chart on Breast cancer - Market size and forecast 2024-2029 ($ million)
Exhibits49: Data Table on Breast cancer - Market size and forecast 2024-2029 ($ million)
Exhibits50: Chart on Breast cancer - Year-over-year growth 2024-2029 (%)
Exhibits51: Data Table on Breast cancer - Year-over-year growth 2024-2029 (%)
Exhibits52: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits53: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits54: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits55: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits56: Market opportunity by Indication ($ million)
Exhibits57: Data Table on Market opportunity by Indication ($ million)
Exhibits58: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits59: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits60: Chart on Comparison by Distribution Channel
Exhibits61: Data Table on Comparison by Distribution Channel
Exhibits62: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits66: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits67: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits68: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits69: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits70: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits71: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits72: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits73: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits74: Market opportunity by Distribution Channel ($ million)
Exhibits75: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits78: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits137: Market opportunity By Geographical Landscape ($ million)
Exhibits138: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits139: Impact of drivers and challenges in 2024 and 2029
Exhibits140: Overview on criticality of inputs and factors of differentiation
Exhibits141: Overview on factors of disruption
Exhibits142: Impact of key risks on business
Exhibits143: Companies covered
Exhibits144: Company ranking index
Exhibits145: Matrix on companies position and classification
Exhibits146: Amgen Inc. - Overview
Exhibits147: Amgen Inc. - Product / Service
Exhibits148: Amgen Inc. - Key news
Exhibits149: Amgen Inc. - Key offerings
Exhibits150: SWOT
Exhibits151: ASSERTIO HOLDINGS INC. - Overview
Exhibits152: ASSERTIO HOLDINGS INC. - Product / Service
Exhibits153: ASSERTIO HOLDINGS INC. - Key offerings
Exhibits154: SWOT
Exhibits155: AstraZeneca Plc - Overview
Exhibits156: AstraZeneca Plc - Product / Service
Exhibits157: AstraZeneca Plc - Key news
Exhibits158: AstraZeneca Plc - Key offerings
Exhibits159: SWOT
Exhibits160: Boehringer Ingelheim International GmbH - Overview
Exhibits161: Boehringer Ingelheim International GmbH - Product / Service
Exhibits162: Boehringer Ingelheim International GmbH - Key news
Exhibits163: Boehringer Ingelheim International GmbH - Key offerings
Exhibits164: SWOT
Exhibits165: Bristol Myers Squibb Co. - Overview
Exhibits166: Bristol Myers Squibb Co. - Product / Service
Exhibits167: Bristol Myers Squibb Co. - Key news
Exhibits168: Bristol Myers Squibb Co. - Key offerings
Exhibits169: SWOT
Exhibits170: Checkpoint Therapeutics Inc. - Overview
Exhibits171: Checkpoint Therapeutics Inc. - Product / Service
Exhibits172: Checkpoint Therapeutics Inc. - Key offerings
Exhibits173: SWOT
Exhibits174: Eli Lilly and Co. - Overview
Exhibits175: Eli Lilly and Co. - Product / Service
Exhibits176: Eli Lilly and Co. - Key offerings
Exhibits177: SWOT
Exhibits178: F. Hoffmann La Roche Ltd. - Overview
Exhibits179: F. Hoffmann La Roche Ltd. - Business segments
Exhibits180: F. Hoffmann La Roche Ltd. - Key news
Exhibits181: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits182: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits183: SWOT
Exhibits184: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibits185: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibits186: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
Exhibits187: SWOT
Exhibits188: Johnson and Johnson Inc. - Overview
Exhibits189: Johnson and Johnson Inc. - Business segments
Exhibits190: Johnson and Johnson Inc. - Key news
Exhibits191: Johnson and Johnson Inc. - Key offerings
Exhibits192: Johnson and Johnson Inc. - Segment focus
Exhibits193: SWOT
Exhibits194: Novartis AG - Overview
Exhibits195: Novartis AG - Business segments
Exhibits196: Novartis AG - Key news
Exhibits197: Novartis AG - Key offerings
Exhibits198: Novartis AG - Segment focus
Exhibits199: SWOT
Exhibits200: Otsuka Holdings Co. Ltd. - Overview
Exhibits201: Otsuka Holdings Co. Ltd. - Business segments
Exhibits202: Otsuka Holdings Co. Ltd. - Key news
Exhibits203: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits204: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits205: SWOT
Exhibits206: Pfizer Inc. - Overview
Exhibits207: Pfizer Inc. - Product / Service
Exhibits208: Pfizer Inc. - Key news
Exhibits209: Pfizer Inc. - Key offerings
Exhibits210: SWOT
Exhibits211: Puma Biotechnology Inc. - Overview
Exhibits212: Puma Biotechnology Inc. - Product / Service
Exhibits213: Puma Biotechnology Inc. - Key offerings
Exhibits214: SWOT
Exhibits215: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits216: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits217: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits218: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits219: SWOT
Exhibits220: Inclusions checklist
Exhibits221: Exclusions checklist
Exhibits222: Currency conversion rates for US$
Exhibits223: Research methodology
Exhibits224: Information sources
Exhibits225: Data validation
Exhibits226: Validation techniques employed for market sizing
Exhibits227: Data synthesis
Exhibits228: 360 degree market analysis
Exhibits229: List of abbreviations